经尿道汽化电切术治疗高危前列腺增生症87例临床观察

Clinical observation on 87 cases of benign prostatic hyperplasia in the treatment of transurethral vaporization resection

目的:探讨经尿道前列腺汽化电切术(TUVP)治疗高危前列腺增生症(BPH)的临床效果和安全性。方法:对87例高危前列腺增生症患者行TUVP手术治疗的临床资料进行分析。结果:手术均获成功,本组患者的手术时间为(53.8±21.2)min;术中出血量(397.4±142.7)ml、切除组织量平均(26.8±5.6)g。术后2个月国际前列腺症状评分(IPSS)、生活质量评分(QOL)、剩余尿量(RUV)、最大尿流率(MFR)、平均尿流率(AFR)与术前比较,差异有统计学意义(P<0.05)。结论:TUVP治疗高危BPH创伤小、安全性高、疗效确切、并发症少,是一种安全、理想的术式。

Objective： To evaluate the clinical efficacy and safety of transurethral resection of prostate（TUVP） in the treat- ment of benign prostatic hyperplasia （BPH）. Methods： Clinical data of 87 patients with benign prostatic hyperplasia in the treatment of TUVP surgery were analyzed. Results： The operations were successful,the operative time was （53.8±21.2） min; blood loss （397.4±142.7） ml, the average amount of removed tissue （26.8±5.6） g.2 months later, the international prostate symptom score （IPSS）, quality of life score （QOL）, residual urine volume （RUV）, maximum urinary flow rate （MFR）, and average urinary flow rate （AFR）had significant difference （P〈0.05）compared with the preoperative. Conclusion： TUVP in the treatment of high risk is safe, effective and ideal way with less complications.